Global Pharmaceutical Leadership

Michael is an accomplished global pharmaceutical executive with nearly 30 years of experience. Here he shares his insights on leadership and his extensive knowledge of the pharmaceutical and healthcare industries.

Learn About Michael

Read The Blog

The Simmering Global Threat of Antimicrobial Resistance

Without new antibiotic development, our society is doomed to reverse the last century of medical progress. On Monday, life-science...

Dec 31, 2024

Pharma’s Year-in-Review 2024

2024 was a busy and eventful year for pharma; year-to-date the FDA granted 46 new drug approvals.

Oct 15, 2024

Effective Early Intervention in Disease Outbreaks is Anything BUT Radical

We have a new(ish) outbreak in the world: mpox (formerly monkeypox).

Global Pharmaceutical Leadership

The Simmering Global Threat of Antimicrobial Resistance

Pharma’s Year-in-Review 2024

Effective Early Intervention in Disease Outbreaks is Anything BUT Radical

Michael's Newsletter